AGF U.S. Market Neutral Anti-Beta Fund (NYSEARCA:BTAL) Sees Large Growth in Short Interest

AGF U.S. Market Neutral Anti-Beta Fund (NYSEARCA:BTAL) was the target of a significant growth in short interest in July. As of July 31st, there was short interest totaling 968,046 shares, a growth of 238.1% from the July 15th total of 286,322 shares. Based on an average trading volume of 799,324 shares, the days-to-cover ratio is presently 1.2 days. Currently, 3.8% of the company’s stock are short sold.

Institutional Trading of AGF U.S. Market Neutral Anti-Beta Fund

Institutional investors and hedge funds have recently bought and sold shares of the company. Crescent Grove Advisors LLC purchased a new position in shares of AGF U.S. Market Neutral Anti-Beta Fund during the first quarter valued at approximately $6,614,000. Advisory Services Network LLC boosted its holdings in AGF U.S. Market Neutral Anti-Beta Fund by 2,091.7% in the fourth quarter. Advisory Services Network LLC now owns 329,604 shares of the company’s stock worth $4,743,000 after purchasing an additional 314,565 shares during the last quarter. PMV Capital Advisers LLC grew its position in AGF U.S. Market Neutral Anti-Beta Fund by 14.0% in the 1st quarter. PMV Capital Advisers LLC now owns 246,621 shares of the company’s stock worth $3,443,000 after purchasing an additional 30,234 shares during the period. Bank of New York Mellon Corp grew its position in AGF U.S. Market Neutral Anti-Beta Fund by 59.4% in the 1st quarter. Bank of New York Mellon Corp now owns 27,235 shares of the company’s stock worth $380,000 after purchasing an additional 10,146 shares during the period. Finally, Worth Asset Management LLC raised its stake in AGF U.S. Market Neutral Anti-Beta Fund by 20.5% during the 1st quarter. Worth Asset Management LLC now owns 30,472 shares of the company’s stock valued at $425,000 after buying an additional 5,190 shares during the last quarter.

AGF U.S. Market Neutral Anti-Beta Fund Stock Down 1.2%

Shares of NYSEARCA BTAL traded down $0.14 during trading on Thursday, reaching $11.79. The company had a trading volume of 130,727 shares, compared to its average volume of 824,752. AGF U.S. Market Neutral Anti-Beta Fund has a 12-month low of $10.86 and a 12-month high of $17.36. The business’s 50-day moving average is $11.70 and its 200 day moving average is $12.75. The stock has a market cap of $296.98 million, a PE ratio of 17.67 and a beta of -0.64.

About AGF U.S. Market Neutral Anti-Beta Fund

The AGFiQ U.S. Market Neutral Anti-Beta Fund (BTAL) is an exchange-traded fund that mostly invests in long\u002Fshort alternatives. The fund is an actively managed fund that takes long positions in low beta US stocks, offset by short positions in high beta US stocks. BTAL was launched on Sep 13, 2011 and is managed by AGF.